Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study
British Journal of Clinical Pharmacology · 2025-08 · 91 (8) · 2327-2339
DOI: 10.1002/bcp.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 13.03.2025. Verfasst von Sam Schoenmakers und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Division of Obstetrics and Fetal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the N…. Hauptthemen laut MEDLINE: Betamethasone, Pre-Eclampsia, Placenta, Glucocorticoids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Scholarship Council.
Abstract (Originalsprache)
Aims
To enhance understanding of betamethasone and its metabolites' pharmacokinetics in pregnancy, specifically early‐onset pre‐eclampsia, through a population pharmacokinetic model. Additionally, to investigate the placental metabolism and transfer of betamethasone and its main metabolites.
Methods
A prospective, single‐centre pharmacokinetic study was conducted in pregnant women ( n = 28) with imminent preterm birth treated with intramuscular betamethasone. Betamethasone serum concentrations were determined from serial venous blood samples ( n = 194). Placental transfer and metabolism were studied using ex vivo human placental perfusion (healthy term; n = 3) and placental explant experiments (healthy term, n = 4; early‐onset pre‐eclampsia, n = 4). Additionally, placental mRNA expression of CYP3A4, CYP3A7, 11β‐hydroxysteroid dehydrogenase (HSD) 1 and 11β‐HSD2 were quantified in healthy and early‐onset pre‐eclampsia placentas.
Results
The population pharmacokinetic model was best described by a 2‐compartment nonlinear mixed effects model. Betamethasone clearance in early‐onset pre‐eclamptic women was 60% lower of that observed in women without pre‐eclampsia (9.35 vs . 15.78 L/h), resulting in a 40% median increase in maternal betamethasone exposure (1567 vs . 1114 ng h/mL). Ex vivo experiments showed placental transfer of betamethasone to the foetal circulation (foetal‐to‐maternal ratio 0.76 ± 0.05 [in a perfused placental cotyledon]). The placenta only converted betamethasone into 11‐ketobetamethasone, with similar ratios in early‐onset pre‐eclampsia and healthy placental explants (3.0 ± 2.2 vs . 1.4 ± 0.4 per mg tissue, P = .27). The expression of 11β‐HSD1 mRNA was lower in early‐onset pre‐eclampsia placentas ( P = .015), while placental CYP3A7 and 11β‐HSD2 mRNA expression were similar.
Conclusion
Women with early‐onset pre‐eclampsia have elevated betamethasone exposure. Betamethasone transfers freely into the foetal circulation, with placental metabolism resulting only in 11‐ketobetamethasone. Decreased placental 11β‐HSD1 expression may play a role in increased betamethasone exposure in early‐onset pre‐eclampsia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Division of Obstetrics and Fetal Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Department of Hospital Pharmacy, Erasmus University Medical Center, The Netherlands.
- Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Erasmus MC University Hospital, Rotterdam, The Netherlands.
- Department of Pediatrics, Division of Neonatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
- Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
- Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
ORCID-Profile: Sam Schoenmakers, Letao Li, Anna C M Kluivers, Michelle Broekhuizen, Madhavi S Harhangi, A H Jan Danser, Irwin Reiss, Karel Allegaert, Sjoerd A A van den Berg, Bertrand D van Zelst, Ron H N van Schaik, Philip L J DeKoninck, Emma Ronde, Sebastiaan D T Sassen, Sinno H P Simons, Birgit C P Koch
Förderung
- China Scholarship Council
Zitieren
APA
Schoenmakers, S., Li, L., Kluivers, A. C. M., Broekhuizen, M., Harhangi, M. S., Danser, A. H. J., Reiss, I., Allegaert, K., van den Berg, S. A. A., van Zelst, B. D., van Schaik, R. H. N., DeKoninck, P. L. J., Ronde, E., Sassen, S. D. T., Simons, S. H. P., & Koch, B. C. P. (2025). Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study. British Journal of Clinical Pharmacology, 91(8), 2327-2339. https://doi.org/10.1002/bcp.70035
Vancouver
Schoenmakers S, Li L, Kluivers ACM, Broekhuizen M, Harhangi MS, Danser AHJ, et al. Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study. British Journal of Clinical Pharmacology. 2025;91(8):2327-2339. doi:10.1002/bcp.70035
BibTeX
@article{Schoenmakers2025,
author = {Schoenmakers, Sam and Li, Letao and Kluivers, Anna C M and Broekhuizen, Michelle and Harhangi, Madhavi S and Danser, A H Jan and Reiss, Irwin and Allegaert, Karel and van den Berg, Sjoerd A A and van Zelst, Bertrand D and van Schaik, Ron H N and DeKoninck, Philip L J and Ronde, Emma and Sassen, Sebastiaan D T and Simons, Sinno H P and Koch, Birgit C P},
title = {Pharmacokinetics of betamethasone in pre‐eclampsia: An in vivo and ex vivo study},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
volume = {91},
number = {8},
pages = {2327--2339},
doi = {10.1002/bcp.70035}
}
EUVIMED